Thursday, June 2, 2016

AstraZeneca sells EU, Latam gout drug rights to Gruenenthal

LONDON, June 2 (Reuters) - AstraZeneca has sold the

European and Latin American rights to its new gout drug Zurampic

to private German drugmaker Gruenenthal for up to $230 million,

following a...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)